SCHEMBL5636281

SCHEMBL5636281

CS(=O)(=O)OCCNC(=O)c1ccc(F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
HDAC3 O15379 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7967927 0.84 NPC1 (0.50) NPC1RAB9AL3MBTL1HDAC3SMN1; SMN2
SCHEMBL5177621 0.83 MEN1 (0.60) NPC1RAB9AHDAC3SMN1; SMN2HPGD
Acetic Acid SCHEMBL6453507 0.81 KDM4E (0.50) NPC1RAB9AL3MBTL1HDAC3SMN1; SMN2
SCHEMBL5671148 0.80 RAB9A (0.56) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL13753140 0.78 L3MBTL1 (0.54) NPC1RAB9AL3MBTL1HDAC3HPGD
SCHEMBL27816160 0.77 CES2 (0.44) RAB9AHPGDALDH1A1CES2CES1
SCHEMBL5636971 0.76 ALPL (0.55) NPC1RAB9AL3MBTL1HDAC3ALDH1A1
SCHEMBL12462063 0.76 HDAC3 (0.54) NPC1RAB9AL3MBTL1HDAC3CES2
SCHEMBL21210764 0.76 HTT (0.58) NPC1RAB9AL3MBTL1HDAC3SMN1; SMN2
SCHEMBL5638410 0.75 CES2 (0.41) L3MBTL1CES2CES1KMT2AACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
EP-1192165-B1 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-09-22 EP disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed